Mehta Vimal

Average Profitability
91.12%
Insider Buys Quantity
9
Insider Buys Sum
$148,161.40
Insider Sells Quantity
12
Insider Sells Sum
$32.06M

Insider Activity of Mehta Vimal

According to the SEC Form 4 filings, Mehta Vimal, being in a position of

  1. CEO and President at BioXcel Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1439995 shares for $424,195,
    over all time since 2018-03-12, has bought 21914 shares for $148,161, and sold 2505789 shares for $32.06M.

The largest purchase of all time was on 2019-08-15 and amounted to 5250 shares of BioXcel Therapeutics, Inc. for $45,518.

The largest sale of all time was on 2021-06-25 and amounted to 946500 shares of BioXcel Therapeutics, Inc. for $29.18M.

Biography of Mehta Vimal

No biography is available at this moment.

2024-12-16SaleBioXcel Therapeutics, Inc.
BTAI
CEO and President
3,117
0.0062%
$0.36$1,131-14.76%
2024-09-16SaleBioXcel Therapeutics, Inc.
BTAI
CEO and President
1,982
0.0052%
$0.69$1,367-13.25%
2024-06-17SaleBioXcel Therapeutics, Inc.
BTAI
CEO and President
2,134
0.0051%
$1.28$2,739-53.95%
2024-06-05SaleBioXcel Therapeutics, Inc.
BTAI
CEO and President
409,136
0.3263%
$0.49$199,619-60.7%
2024-06-04SaleBioXcel Therapeutics, Inc.
BTAI
CEO and President
1.02M
0.3359%
$0.20$205,516-61.03%
2024-04-04SaleBioXcel Therapeutics, Inc.
BTAI
CEO and President
5,268
0.0153%
$2.62$13,823-73.24%
2023-06-16SaleBioXcel Therapeutics, Inc.
BTAI
CEO and President
30,000
0.1052%
$20.18$605,501-84.58%
2023-06-15SaleBioXcel Therapeutics, Inc.
BTAI
CEO and President
30,000
0.105%
$21.54$646,226-85.58%
2023-05-22SaleBioXcel Therapeutics, Inc.
BTAI
CEO and President
6,500
0.0226%
$25.79$167,641-87.62%
2022-12-16SaleBioXcel Therapeutics, Inc.
BTAI
CEO and President
30,000
0.1038%
$19.44$583,320-12.62%
2022-12-15SaleBioXcel Therapeutics, Inc.
BTAI
CEO and President
22,794
0.08%
$19.86$452,689-12.9%
2021-06-25SaleBioXcel Therapeutics, Inc.
BTAI
CEO, President and Secretary
946,500
3.7611%
$30.83$29.18M-29.86%
2019-08-16PurchaseBioXcel Therapeutics, Inc.
BTAI
CEO, President and Secretary
1,948
0.006%
$4.45$8,659+104.92%
2019-08-15PurchaseBioXcel Therapeutics, Inc.
BTAI
CEO, President & Secretary
5,250
0.0333%
$8.67$45,518+114.13%
2019-08-14PurchaseBioXcel Therapeutics, Inc.
BTAI
CEO, President & Secretary
716
0.0045%
$8.44$6,043+117%
2019-08-13PurchaseBioXcel Therapeutics, Inc.
BTAI
CEO, President & Secretary
2,000
0.0126%
$8.75$17,500+108.29%
2018-12-14PurchaseBioXcel Therapeutics, Inc.
BTAI
CEO, President, Secretary
4,000
0.0313%
$4.38$17,532+138.28%
2018-12-04PurchaseBioXcel Therapeutics, Inc.
BTAI
CEO, President, Secretary
2,000
0.0145%
$5.13$10,270+88.27%
2018-12-03PurchaseBioXcel Therapeutics, Inc.
BTAI
CEO, President, Secretary
2,000
0.0139%
$5.17$10,339+79.76%
2018-11-30PurchaseBioXcel Therapeutics, Inc.
BTAI
CEO, President, Secretary
2,000
0.0146%
$5.15$10,301+89.65%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.